April 15, 2014 | By DEEPTI RAMESH
Mitsubishi Chemical subsidiary and Neuland open pharma ingredients plant in India Neuland Laboratories (Hyderabad, India), a pharmaceutical manufacturer that provides active pharmaceutical ingredients (APIs), complex intermediates, and contract manufacturing services, says that it has opened a new manufacturing facility at Hyderabad, constructed as part of its previously announced collaboration with API...
April 11, 2014 | By LINDSAY FROST
This Week in CW: Several companies reported first quarter earnings this week as the season begins. Givaudan (Geneva) recorded sales of 1.09 billion Swiss francs ($1.24 billion). The results are down 0.2% in Swiss franc terms compared with figures reported in the first quarter of last year. Leading potash producer Uralkali (Berezniki, Russia) says its 2013 net profit dropped 58%, to $666 million on revenue...
April 8, 2014 | By DEEPTI RAMESH
FDA issues warning letter to GlaxoSmithKline’s API plant in Ireland The US FDA issued a warning letter on 18 March to the active pharmaceutical ingredient (API) manufacturing facility of GlaxoSmithKline (GSK; London) located at Carrigaline in the county of Cork, Ireland, for violations of cGMP. An FDA inspection from 18–23 October 2013 at the Carrigaline facility identified deviations from cGMP...
April 4, 2014 | By LINDSAY FROST
This Week in CW: Momentive Performance Materials (MPM; Albany, NY), the silicones and quartz subsidiary of Momentive, is considering a bankruptcy filing as part of ongoing negotiations to reduce debt. “As part of this process, a filing under Chapter 11 of the US Bankruptcy Code may provide the most expeditious manner in which to affect a plan of reorganization,” MPM said in a regulatory filing...
April 1, 2014 | By DEEPTI RAMESH
China to better supervise drug safety The Chinese government says it will establish a more rigorous supervision system this year, for food and drug safety. Harsh punishments would be handed out to those who violate food and drug safety laws, the government says. A police division dedicated to food and drug safety may also be established. The China Food and Drug Administration (CFDA; Beijing) worked closely...
March 28, 2014 | By LINDSAY FROST
This Week in CW: IHS Chemical’s 2014 World Petrochemical Conference kicked off this week—with the central theme being the shifting landscape of petrochemicals, both at home and abroad, due to the shale boom. The shale revolution will dramatically affect the global distribution of chemical industry profits, says Dave Witte,senior v.p. of IHS and general manager of IHS Chemical. Earnings in North...
March 26, 2014 | By DEEPTI RAMESH
AMRI to acquire API firm Cedarburg Albany Molecular Research Inc. (AMRI; Albany, NY) says that it has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Hauser Pharmaceuticals (Grafton, WI), for $38.2 million in cash. The transaction, including $2.8 million of assumed liabilities, is valued at $41 million. Cedarburg is a contract developer and manufacturer of technically...
March 21, 2014 | By LINDSAY FROST
This Week in CW: Dow Chemical said at an investor meeting in Saudi Arabia on 19 March that it has increased its asset sale target by $1.5–2.0 billion, lifting expected proceeds to $4.5–6.0 billion. This target includes the previously announced divestment of chlor-alkali and epoxy chain businesses. Dow says it expects pretax proceeds of $3–4 billion from the divestment of those businesses...
March 18, 2014 | By DEEPTI RAMESH
DSM and JLL create $2-billion pharma services firm DPx DSM and private equity firm JLL Partners (New York) say that they have created DPx Holdings, a new privately held company, by combining DSM Pharmaceutical Products (Parsippany, NJ), the custom manufacturing and technology business of DSM, with Patheon (Toronto), a portfolio company of JLL. DSM and JLL first announced plans to create the new company in...
March 14, 2014 | By LINDSAY FROST
This Week in CW: FMC has announced plans to separate into two independent public companies: New FMC, which will comprised FMC's agricultural solutions and health and nutrition segments; and FMC Minerals, which will comprised FMC's current minerals segment, consisting of the alkali chemicals and lithium businesses. The company expects the separation, which remains subject to final board approval and other...
ABOUT CHEM IDEAS
Welcome to Chem Ideas, the place for opinions and perspective on the key issues affecting the global chemicals industry. This zone features articles by Chemweek’s regular editors as well as a team of established experts with insights across the chemicals industry. If you would like to contribute a blog or opinion piece contact Lindsay.Frost@ihs.com.
CLICK HERE TO LEARN ABOUT CHEMWEEK'S EDITORS
ABOUT OUR GUEST AUTHORS
Fine Chemicals / Pharma
Girish Malhotra is the president and founder of Epcot International, an international consulting firm covering chemical manufacture. Girish is an established industry figure having held senior positions at companies including ExxonMobil and Sherwin Williams. He can be reached at email@example.com
Lawrence D. Sloan became Socma's
President in early 2010. He says he will continue to drive up the interests of his members on issues including regulation and best business practice.
Lisa Allen is the Technical Manager of ReachReady, the Reach services body affiliated to the Chemical Industries Assocation (CIA; U.K.).
She spends much of her time addressing concerns raised by ReachReady’s customers about Reach.
Kathryn Sheridan is the founder of Sustainability Consult, providing public relations support with a sustainability focus to a number of chemical industry clients, as well as to other sectors. Sustainability Consult helps organisations develop, promote and communicate their sustainability strategies, plans and activities. firstname.lastname@example.org
Rubber and Plastics
Lou Reade is a freelance journalist and expert in the rubber and plastics fields. Based in the U.K. Lou has more than a decade writing in about rubber and plastics manufacture with a wealth of experience gained while writing for the leading publications in the field in the U.K. and wider afield. Loureade@talk21.com.
Giles Chappell is an attorney based in Geneva. His practice focuses on chemicals—specifically REACH and the CLP Regulation, product safety legislation, environmental and trade compliance, and market access issues. He was recommended in 2012 by the Chambers & Partners legal directory. email@example.com
Steve Roberts is an attorney who practices in the rapidly developing area of homeland security law and regulation. Steve writes and speaks frequently on the legal aspects of homeland security and counterterrorism affecting the nation’s critical infrastructure. www.chemicalsecurity.com